3 Abr 2020 | News
COVID-19 patients suffering from severe forms of the disease are at risk of developing bacterial healthcare-associated infections, such as ventilator-associated pneumonia caused by multidrug resistant pathogens. TP-122 bacteriophage cocktail may be an alternative for...
31 Jul 2019 | News
TechnoPhage is currently looking for a Head of Neuroscience/Ophthalmology (PhD) with a strong scientific background to lead a team dedicated to characterize and understand the function of therapeutics against a large range of targets. Click here to know...
19 Jul 2019 | News
Technophage S.A., in collaboration with a team led by Leonor Saúde, Principal Investigator of the Instituto de Medicina Molecular João Lobo Antunes (iMM), developed a simple, fast and efficient zebrafish screening platform to discover and select new therapeutics for...
28 Jun 2019 | News
The United States Patent and Trademark Office recently issued a notice of allowance for US patent application number 15/568,655 covering Technophage’s TZ-113 project. TZ-113 is a repurposing project for Parkinson’s patients targeting levodopa induced...
6 Mai 2019 | News
TechnoPhage’s CEO Miguel Garcia will attend the 11th Annual International Partnering Conference ChinaBio® Partnering Forum on May 8-9 in Shangai, China. If you wish to meet us at the conference feel free to contact us to info@technophage.pt to schedule a...
